Chronic myeloid leukemia following treatment for bilateral retinoblastoma

Pediatr Blood Cancer. 2018 Sep;65(9):e27107. doi: 10.1002/pbc.27107. Epub 2018 May 4.

Authors

Tatsuya Kamitori¹, Katsutsugu Umeda¹, Keiji Tasaka¹, Hideto Ogata¹, Takashi Mikami¹, Itaru Kato¹, Hidefumi Hiramatsu¹, Tadakazu Kondo², Souichi Adachi³

Affiliations

¹ Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
³ Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 29727044
DOI: 10.1002/pbc.27107

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Brachytherapy / adverse effects*
Combined Modality Therapy
Cryotherapy
Dasatinib / therapeutic use
Eye Enucleation
Humans
Infant
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
Light Coagulation
Male
Melphalan / therapeutic use
Neoplasms, Multiple Primary / therapy*
Neoplasms, Radiation-Induced / drug therapy
Neoplasms, Radiation-Induced / etiology*
Neoplasms, Second Primary / drug therapy
Neoplasms, Second Primary / etiology*
Radiotherapy, Adjuvant / adverse effects*
Remission Induction
Retinoblastoma / therapy*

Substances

Melphalan
Dasatinib